CN1198623C - 含环索奈德的含水药物组合物 - Google Patents

含环索奈德的含水药物组合物 Download PDF

Info

Publication number
CN1198623C
CN1198623C CNB00814253XA CN00814253A CN1198623C CN 1198623 C CN1198623 C CN 1198623C CN B00814253X A CNB00814253X A CN B00814253XA CN 00814253 A CN00814253 A CN 00814253A CN 1198623 C CN1198623 C CN 1198623C
Authority
CN
China
Prior art keywords
pharmaceutical composition
ciclesonide
aqueous pharmaceutical
composition according
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB00814253XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1379673A (zh
Inventor
A·纳加诺
Y·尼施贝
K·塔卡纳施
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kevis Pharmaceutical Co ltd
Original Assignee
AUSTANA PHARMACEUTICAL GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1198623(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AUSTANA PHARMACEUTICAL GmbH filed Critical AUSTANA PHARMACEUTICAL GmbH
Publication of CN1379673A publication Critical patent/CN1379673A/zh
Application granted granted Critical
Publication of CN1198623C publication Critical patent/CN1198623C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB00814253XA 1999-10-20 2000-10-20 含环索奈德的含水药物组合物 Expired - Lifetime CN1198623C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP298186/1999 1999-10-20
JP29818699 1999-10-20
JP298186/99 1999-10-20

Publications (2)

Publication Number Publication Date
CN1379673A CN1379673A (zh) 2002-11-13
CN1198623C true CN1198623C (zh) 2005-04-27

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB00814253XA Expired - Lifetime CN1198623C (zh) 1999-10-20 2000-10-20 含环索奈德的含水药物组合物

Country Status (35)

Country Link
US (2) US8383611B1 (enExample)
EP (1) EP1227817B1 (enExample)
JP (1) JP4856338B2 (enExample)
KR (1) KR100705372B1 (enExample)
CN (1) CN1198623C (enExample)
AR (1) AR026073A1 (enExample)
AT (1) ATE270107T1 (enExample)
AU (1) AU776587B2 (enExample)
BG (1) BG65799B1 (enExample)
BR (1) BRPI0014880B8 (enExample)
CA (1) CA2388325C (enExample)
CO (1) CO5251406A1 (enExample)
CZ (1) CZ297780B6 (enExample)
DE (1) DE60011924T2 (enExample)
DK (1) DK1227817T3 (enExample)
EA (1) EA005201B1 (enExample)
ES (1) ES2223595T3 (enExample)
HR (1) HRP20020345B1 (enExample)
HU (1) HU228894B1 (enExample)
IL (2) IL148725A0 (enExample)
ME (1) ME00568A (enExample)
MX (1) MXPA02003975A (enExample)
MY (1) MY121175A (enExample)
NO (1) NO327379B1 (enExample)
NZ (1) NZ518299A (enExample)
PE (1) PE20010713A1 (enExample)
PL (1) PL197537B1 (enExample)
PT (1) PT1227817E (enExample)
RS (1) RS50345B (enExample)
SI (1) SI1227817T1 (enExample)
SK (1) SK286194B6 (enExample)
TR (1) TR200200831T2 (enExample)
TW (1) TWI269655B (enExample)
WO (1) WO2001028563A1 (enExample)
ZA (1) ZA200203078B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
EP1519734A4 (en) * 2002-07-02 2011-02-23 Nycomed Gmbh CICLESONIC STERILE AQUEOUS SUSPENSION
MXPA05001885A (es) 2002-08-30 2005-06-03 Altana Pharma Ag El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
AU2003293833B2 (en) 2002-12-12 2009-10-01 Covis Pharma B.V. Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2006055954A2 (en) * 2004-11-17 2006-05-26 Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Steroid formulation and methods of treatment using same
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
DK2262506T3 (da) 2008-03-11 2014-06-10 Alcon Res Ltd Meget flokkulerede triamcinolonacetonid-suspensioner med lav viskositet til intravitreal injektion
CA2844944A1 (en) 2011-08-18 2013-02-21 Takeda Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
AU565354B2 (en) 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
DK0431719T3 (da) 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1992020343A1 (en) 1991-04-03 1992-11-26 Gunderson Medical Foundation, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
PT943326E (pt) 1996-02-27 2003-12-31 Teijin Ltd Composicao em po para administracao nasal
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
CN1158995C (zh) 1998-01-22 2004-07-28 参天制药株式会社 氟米龙眼用混悬液
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
CN1327381A (zh) 1999-10-20 2001-12-19 帝人株式会社 水性药物组合物
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida

Also Published As

Publication number Publication date
AR026073A1 (es) 2002-12-26
SI1227817T1 (en) 2004-12-31
HRP20020345B1 (en) 2006-12-31
ATE270107T1 (de) 2004-07-15
DE60011924D1 (de) 2004-08-05
MY121175A (en) 2005-12-30
CZ297780B6 (cs) 2007-03-28
ME00568B (me) 2011-12-20
CA2388325A1 (en) 2001-04-26
IL148725A0 (en) 2002-09-12
PE20010713A1 (es) 2001-07-13
DK1227817T3 (da) 2004-11-15
SK286194B6 (sk) 2008-05-06
ES2223595T3 (es) 2005-03-01
HU228894B1 (hu) 2013-06-28
US20130095146A1 (en) 2013-04-18
EP1227817B1 (en) 2004-06-30
SK6932002A3 (en) 2002-09-10
BR0014880A (pt) 2002-06-11
EA005201B1 (ru) 2004-12-30
MXPA02003975A (es) 2003-09-25
IL148725A (en) 2006-12-31
PT1227817E (pt) 2004-11-30
US8383611B1 (en) 2013-02-26
HRP20020345A2 (en) 2005-10-31
BRPI0014880B1 (pt) 2015-08-11
CZ20021284A3 (cs) 2002-07-17
KR20020060205A (ko) 2002-07-16
EP1227817A1 (en) 2002-08-07
NZ518299A (en) 2004-03-26
RS50345B (sr) 2009-11-10
AU776587B2 (en) 2004-09-16
HUP0203756A2 (en) 2003-05-28
NO20021866L (no) 2002-04-19
DE60011924T2 (de) 2005-07-07
HK1051003A1 (en) 2003-07-18
BRPI0014880B8 (pt) 2021-05-25
EA200200383A1 (ru) 2002-10-31
WO2001028563A1 (en) 2001-04-26
ZA200203078B (en) 2003-01-29
BG106517A (en) 2002-12-29
TR200200831T2 (tr) 2002-07-22
TWI269655B (en) 2007-01-01
JP2003512330A (ja) 2003-04-02
PL197537B1 (pl) 2008-04-30
KR100705372B1 (ko) 2007-04-11
PL356190A1 (en) 2004-06-14
CN1379673A (zh) 2002-11-13
YU28102A (sh) 2004-12-31
HUP0203756A3 (en) 2004-06-28
ME00568A (en) 2011-12-20
CA2388325C (en) 2007-09-18
AU7953200A (en) 2001-04-30
NO327379B1 (no) 2009-06-22
CO5251406A1 (es) 2003-02-28
NO20021866D0 (no) 2002-04-19
BG65799B1 (bg) 2009-12-31
JP4856338B2 (ja) 2012-01-18

Similar Documents

Publication Publication Date Title
US20130095146A1 (en) Ciclesonide containing aqueous pharmaceutical composition
AU757786B2 (en) Formulations of fexofenadine
JP2021046392A5 (enExample)
JP2006516988A (ja) 持続した薬物放出またはムコ粘着のための活性剤およびキトサンを含む製薬組成物
CN1646568A (zh) 用于治疗缺铁性贫血的铁糊精化合物
CN100341567C (zh) 胰岛素的经鼻给药用组合物
CN104902873A (zh) 溶解性差的活性成分的薄膜剂形式的口服和/或含服组合物、其制备方法以及其用途
AU2004278013B2 (en) Polysaccharides for pulmonary delivery of active agents
CN1327381A (zh) 水性药物组合物
CN101065111A (zh) 含有作为非还原甜味剂的山梨糖醇和至少一种活性剂的无染料药物悬浮液
HK1051003B (zh) 含环索奈德的含水药物组合物
CN115737554A (zh) 一种氯巴占口服混悬剂的制备方法
HK1037544A (en) Aqueous medicinal compositions
JPWO2001028517A1 (ja) 水性医薬品組成物

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
ASS Succession or assignment of patent right

Owner name: BYK GULDEN LOMBERG CHEM CO.

Free format text: FORMER OWNER: TEIJIN LTD.

Effective date: 20021018

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20021018

Applicant after: BYK Gulden Lomberg Chemische Fabrik GmbH

Applicant before: TEIJIN Ltd.

ASS Succession or assignment of patent right

Owner name: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH

Free format text: FORMER OWNER: TEIJIN LTD.

Effective date: 20021115

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20021115

Applicant after: BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH

Applicant before: TEIJIN Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NICOMEDES LIMITED LIABILITY COMPANY

Free format text: FORMER NAME OR ADDRESS: OTANA MEDICINE AG

CP03 Change of name, title or address

Address after: Konstanz, Germany

Patentee after: NYCOMED GmbH

Address before: The Federal Republic of Germany Konstanz

Patentee before: ALTANA PHARMA AG

C56 Change in the name or address of the patentee

Owner name: NYCOMED INC.

Free format text: FORMER NAME: NYCOMED GMBH

CP01 Change in the name or title of a patent holder

Address after: Konstanz, Germany

Patentee after: Nycomed GmbH

Address before: Konstanz, Germany

Patentee before: Nycomed GmbH

C56 Change in the name or address of the patentee

Owner name: TAKEDA GMBH

Free format text: FORMER NAME: NYCOMED INC.

CP01 Change in the name or title of a patent holder

Address after: Konstanz, Germany

Patentee after: TAKEDA GmbH

Address before: Konstanz, Germany

Patentee before: Nycomed GmbH

ASS Succession or assignment of patent right

Owner name: NYCOMED GERMANY HOLDING GMBH

Free format text: FORMER OWNER: NYCOMED ASSET MANAGEMENT GMBH

Effective date: 20150619

Owner name: NYCOMED ASSET MANAGEMENT GMBH

Free format text: FORMER OWNER: TAKEDA GMBH

Effective date: 20150619

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: TAKEDA GMBH

Free format text: FORMER NAME: NYCOMED GERMANY HOLDING GMBH

CP01 Change in the name or title of a patent holder

Address after: Konstanz, Germany

Patentee after: TAKEDA GmbH

Address before: Konstanz, Germany

Patentee before: Nycomed Germany holding LLC

TR01 Transfer of patent right

Effective date of registration: 20150619

Address after: Konstanz, Germany

Patentee after: Nycomed asset management LLC

Address before: Konstanz, Germany

Patentee before: TAKEDA GmbH

Effective date of registration: 20150619

Address after: Konstanz, Germany

Patentee after: Nycomed Germany holding LLC

Address before: Konstanz, Germany

Patentee before: Nycomed asset management LLC

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20170105

Address after: Swedish Suo de Jie

Patentee after: ASTRAZENECA AB

Address before: Konstanz, Germany

Patentee before: TAKEDA GmbH

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190604

Address after: Swiss Swiss

Patentee after: Kevis Pharmaceutical Co.,Ltd.

Address before: Swedish Suo de Jie

Patentee before: ASTRAZENECA AB

CX01 Expiry of patent term

Granted publication date: 20050427

CX01 Expiry of patent term